Why is Axon Enterprise stock rebounding today?

Investor interest is driving notable price movements in several stocks today. Axon Enterprise's rebound follows a strong earnings beat and guidance upgrade, while Sharplink's slide is tied to a disappointing product launch. Immunovant's surge is driven by positive clinical trial results, and RB Global's rally reflects a strategic acquisition announcement. The varied moves highlight how company‑specific catalysts influence investor behavior.